A look at the Mechanism of Action of IL13 and IL13/4 Inhibitors in Atopic Dermatitis
This video explains the mechanism of action for IL-13 and IL-13/4 inhibitors in moderate-to-severe atopic dermatitis, featuring dupilumab, tralokinumab, and lebrikizumab with expert narration and visual animations.
Date of Last Review: September 25, 2025
Document Number: VV-MED-153971
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice